Pharmaceuticals 2011 - Construction of the European Drug Master File (EDMF) for Regulatory Agencies
Date2011-11-18
Deadline2011-11-18
VenuePalo Alto, USA - United States
KeywordsEuropean Drug Master File;EDMF;Recordkeeping Requirements;CTD Rules;Common Technical Documentation
Topics/Call fo Papers
This webinar will cover a step-by-step process to construct and submit the European Drug Master File (EDMF), recordkeeping requirements and manufacturer responsibilities.
Why Should You Attend:
Drug master files serve as documentation on the quality of an active ingredient or excipient and are submitted by a manufacturer as part of the licensing or amendment procedure. The DMF should be submitted in the format described in the Common Technical Document (CTD) Part 3.2.S.
This Webinar will focus on the European Community procedure where information can be provided to the authorities and the applicant, where the active substance manufacturer is not the applicant for a product marketing authorization, with a view to protecting valuable manufacturing know-how. This session will use the words “medicinal products” and these cover both products for use in humans and veterinary products. This Webinar will focus on the European, not FDA’s DMF or Master File.
Other CFPs
- FDA's DDMAC Compliance: Current Issues and Emerging Perspectives
- 2012 International Conference on Green Buildings and Optimization Design (GBOD 2012)
- Understanding ISO 14644-1: What is Required of Pharmaceutical Manufacturers
- 4th International Congress on Cell Membranes and Oxidative Stress: Focus on Calcium Signaling and TRP Channels
- Water System Mythology: Common False Beliefs for Microbial Control and Monitoring
Last modified: 2011-09-29 17:26:48